# Assembly Biosciences clinical trials: 23 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 23 trials with Assembly Biosciences as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Assembly Biosciences: 23 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/assembly-biosciences

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 23
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 23 newest of 23, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 1, 2026 | NCT07850999 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Participants With Mild Hepatic Impairment Compared With... | Assembly Biosciences | Phase 1 | Not yet recruiting | Mild Hepatic Imparement | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850999) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| December 18, 2024 | NCT06740474 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants | Assembly Biosciences | Phase 1 | Completed | Hepatitis Delta Virus, Hepatitis D | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06740474) |
| November 21, 2024 | NCT06698575 | A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2... | Assembly Biosciences | Phase 1 | Completed | Recurrent Genital Herpes Simplex Type 2 | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06698575) |
| April 26, 2024 | NCT06385327 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive... | Assembly Biosciences | Phase 1 | Completed | Recurrent Genital Herpes Simplex Type 2 | 115 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06385327) |
| April 25, 2024 | NCT06384131 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06384131) |
| October 6, 2022 | NCT05569941 | A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05569941) |
| June 10, 2022 | NCT05414981 | A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-H3733 in Subjects With Chronic Hepatitis B Virus Infection | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05414981) |
| March 29, 2021 | NCT04820686 | A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection | Assembly Biosciences | Phase 2 | Terminated | Chronic Hepatitis B | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04820686) |
| March 4, 2021 | NCT04781647 | A Study Evaluating ABI-H0731-containing Regimens in Chinese Participants With Chronic Hepatitis B Virus Infection | Assembly Biosciences | Phase 2 | Terminated | Chronic Hepatitis B | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04781647) |
| November 19, 2020 | NCT04637139 | A Study to Evaluate the Mass Balance Absorption and AME of VBR | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04637139) |
| July 1, 2020 | NCT04454567 | A Study Evaluating Treatment Intensification With ABI-H0731 in Participants With Chronic Hepatitis B Infection on Nucleos(t)Ide Reverse... | Assembly Biosciences | Phase 2 | Terminated | Chronic Hepatitis B | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04454567) |
| May 21, 2020 | NCT04398134 | A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection | Assembly Biosciences | Phase 2 | Terminated | Chronic Hepatitis B | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04398134) |
| February 17, 2020 | NCT04271592 | A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABI-H3733 in Healthy Adults | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04271592) |
| October 29, 2019 | NCT04142762 | A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04142762) |
| September 10, 2019 | NCT04083716 | A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04083716) |
| April 22, 2019 | NCT03923478 | ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis | Assembly Biosciences | Phase 1 | Terminated | Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03923478) |
| December 19, 2018 | NCT03780543 | A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients | Assembly Biosciences | Phase 2 | Terminated | Chronic Hepatitis B | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03780543) |
| October 22, 2018 | NCT03714152 | A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03714152) |
| July 5, 2018 | NCT03577171 | A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis... | Assembly Biosciences | Phase 2 | Completed | Chronic Hepatitis B | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03577171) |
| July 3, 2018 | NCT03576066 | A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection | Assembly Biosciences | Phase 2 | Completed | Chronic Hepatitis B | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03576066) |
| April 12, 2017 | NCT03109730 | Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B | Assembly Biosciences | Phase 1/2 | Completed | Chronic Hepatitis B | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03109730) |
| September 20, 2016 | NCT02908191 | A Study in Healthy Volunteers and Patients With Chronic Hepatitis B | Assembly Biosciences | Phase 1 | Completed | Chronic Hepatitis B | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02908191) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 14 |
| Phase 1/2 | 1 |
| Phase 2 | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 15 |
| Terminated | 6 |
| Not yet recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Hepatitis B, Chronic | 17 |
| Hepatitis B | 9 |
| Herpes Genitalis | 2 |
| Hepatitis D | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Theme restaurants in the United States](https://specstream.ai/data/businesses/theme-restaurants/united-states)
- [Food and beverage distributors in the United States](https://specstream.ai/data/businesses/food-and-beverage-distributors/united-states)
- [Tax law firms in the United States](https://specstream.ai/data/businesses/tax-law-firms/united-states)
- [Financial services firms in the United States](https://specstream.ai/data/businesses/financial-services-firms/united-states)
- [Structural engineering firms in the United States](https://specstream.ai/data/businesses/structural-engineering-firms/united-states)
- [Family practice clinics in the United States](https://specstream.ai/data/businesses/family-practice-clinics/united-states)
